However, elevated levels of HMGB1 within the first 24 h after ischemic stroke are considered to be a good predictor of stroke severity and clinical outcome (51), thus serving as a potential therapeutic target (Table 3). This evidence concerns the gene HMGB1 and stroke disorder.